Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Silvia Mioletti is active.

Publication


Featured researches published by Silvia Mioletti.


The International Journal of Biochemistry & Cell Biology | 1997

G proteins and regulation of pyruvate dehydrogenase activity by insulin in human circulating lymphocytes

M. Curto; Marco Piccinini; Ivana Rabbone; Silvia Mioletti; Michael Mostert; R. Bruno; Maria Teresa Rinaudo

Pertussis toxin (PT) catalyzes ADP-ribosylation of G protein alpha subunits, thus preventing their role as transducers of external signals targeting metabolic pathways. In vitro, in human circulating lymphocytes insulin at physiological concentrations (5 microU/ml) determines sharp activation of pyruvate dehydrogenase (PDH), the rate limiting enzyme in glucose oxidative breakdown. This study evaluates whether the above-described effects of insulin over PDH are mediated through G proteins. Human circulating lymphocytes (six samples from different donors) were exposed to insulin (5 microU/ml), PT (1-2 micrograms/ml) or PT-9K, a mutated PT void of catalytic activity (1-10 micrograms/ml), and to insulin in combination with the two toxins, and then assessed for PDH activity. Plasma membranes from cells incubated with and without PT or PT-9K were subjected to ADP-ribosylation in the presence of [32P] NAD+ and activated PT. In circulating lymphocytes exposed to PT alone, or in combination with insulin, PDH activity falls significantly below basal values (P < 0.001); PT-9K instead has no effect on basal or on insulin-stimulated PDH activity. ADP-ribosylation of a plasma membrane component with apparent molecular mass (42 kDa) comparable to that of the Gi (inhibitory) protein alpha subunit takes place in cells exposed to PT but not in those exposed to PT-9K. In human circulating lymphocytes Gi proteins or Gi protein-like components appear to be involved in preserving basal PDH activity as well as in the mechanism by which insulin exerts its control over PDH.


Cell Biochemistry and Function | 2013

Protective effects of polydeoxyribonucleotides on cartilage degradation in experimental cultures

Luisa Gennero; Tetyana Denysenko; Gian Franco Calisti; Andrea Vercelli; Carlo Vercelli; S. Amedeo; Silvia Mioletti; Enrico Parino; Manuela Gessica Montanaro; Antonio Melcarne; Carola Juenemann; Enrico De Vivo; Alessandro Longo; G. P. Cavallo; Rocco De Siena

The capacity of cartilage self‐regeneration is considered to be limited. Joint injuries often evolve in the development of chronic wounds on the cartilage surface. Such lesions are associated with articular cartilage degeneration and osteoarthritis. Re‐establishing a correct micro/macro‐environment into damaged joints could stop or prevent the degenerative processes. This study investigated the effect of polydeoxyribonucleotides (PDRNs) on cartilage degradation in vitro and on cartilage extracted cells. The activities of matrix metalloproteinases 2 and 9 were measured in PDRN‐treated cells and in controls at days 0 and 30 of culture. Human nasal cartilage explants were cultured, and the degree of proteoglycan degradation was assessed by measuring the amount of glycosaminoglycans released into the culture medium. The PDRN properties compared with controls were tested on cartilage tissues to evaluate deposition of extracellular matrix. Chondrocytes treated with PDRNs showed a physiological deposition of extracellular matrix (aggrecan and type II collagen: Western blot, IFA, fluorescence activated cell sorting, Alcian blue and safranin O staining). PDRNs were able to inhibit proteoglycan degradation in cartilage explants. The activities of matrix metalloproteinases 2 and 9 were reduced in all PDRN‐treated samples. Our results indicate that PDRNs are suitable for a long‐term cultivation of in vitro cartilage and have therapeutic effects on chondrocytes by protecting cartilage. Copyright


Archive | 2002

In Vivo Analysis of Cell Proliferation and Apoptosis in the CNS

Laura Lossi; Silvia Mioletti; Patrizia Aimar; R. Bruno; Adalberto Merighi

The balance between cell proliferation and death is fundamental in several morphogenetic processes and ultimately determines the mass, shape, and function of the various tissues and organs that form the animal body. Apoptosis is a gene-regulated process of programmed cell death (PCD) that plays fundamental roles in several normal and pathological conditions (56,126). This form of “cell suicide” is most often detected during embryonic development, but is also found in normal cell and tissue turnover (26,77,81,133). Although the nervous tissue is traditionally regarded as being fundamentally constituted by postmitotic nonproliferating cells, analysis of cell proliferation and apoptosis in vivo has recently gained an increasing importance mainly considering that: (i) proliferative and/or apoptotic events have been extensively characterized not only during embryonic development but also in several areas of the postnatal and adult brain (9,10, 46,63–65,79,97,101); (ii) trophic factor deprivation often results in apoptotic cell death of target neurons (25,82,131); and (iii) links have been hypothesized between apoptosis and signal transduction (31,60).


Journal of Diabetes and Its Complications | 1994

Effect of sulfonylurea agents on pyruvate dehydrogenase activity in circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM)

Maria Teresa Rinaudo; M. Curto; Ivana Rabbone; Marco Piccinini; R. Bruno; Silvia Mioletti; Silvia Gamba

In circulating lymphocytes from patients with non-insulin-dependent diabetes mellitus (NIDDM) subnormal pyruvate dehydrogenase (PDH) activity returns to normal following patient treatment with sulfonylurea (gliclazide, 80 mg twice daily/5 weeks). Moreover, in vitro in cells from diabetic patients exposed to insulin at 50 microU/mL PDH activation also occurs; in cells of controls the same happens for insulin at 5 microU/mL, whereas at 50 microU/mL inhibition takes place. Therefore, the low PDH activity in cells of NIDDM patients might be caused by defective insulin control on the enzyme and its recovery in gliclazide-treated patients by drug-mediated removal of the defect. The validity of the hypothesis was verified in this study where cells of NIDDM patients before and after gliclazide treatment were exposed, in vitro, to insulin at 5 and 50 microU/mL and then tested for PDH activity. In such conditions, the profile of PDH behavior in treated patients was no longer comparable to that in untreated patients but closer to that in euglycemic controls, thus supporting the view that the recovery of PDH activity in NIDDM patients following gliclazide treatment might be the expression of an additional effect that the drug would have in these patients, aimed to renew cell responsiveness to insulin.


Expert Opinion on Drug Delivery | 2018

Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery

Luigi Battaglia; Pier Paolo Panciani; Elisabetta Muntoni; Maria Teresa Capucchio; E. Biasibetti; Pasquale De Bonis; Silvia Mioletti; Marco Fontanella; Shankar Swaminathan

ABSTRACT Introduction: The blood brain barrier is a functional barrier allowing the entry into the brain of only essential nutrients, excluding other molecules. Its structure, although essential to keep the harmful entities out, is also a major roadblock for pharmacological treatment of brain diseases. Several alternative invasive drug delivery approaches, such as transcranial drug delivery and disruption of blood brain barrier have been explored, with limited success and several challenges. Intranasal delivery is a non-invasive methodology, which bypasses the systemic circulation, and, through the intra- and extra- neuronal pathways, provides direct brain drug delivery. Colloidal drug delivery systems, particularly lipidic nanoparticles offer several unique advantages for this goal . Areas covered: This review focuses on key brain diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis, and provide a detailed overview of the current lipid nanoparticle based treatment options explored thus far. The review also delves into basic preparation, challenges and evaluation methods of lipid drug delivery systems. Expert opinion: Brain diseases present complex pathophysiology, in addition to the practically inaccessible brain tissues, hence according to the authors, a two-pronged approach utilizing new target discovery coupled with new drug delivery systems such as lipid carriers must be adopted.


Scientific Reports | 2017

Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis

Fulvia Cerruti; Genny Jocollé; Chiara Salio; Laura Oliva; Luca Paglietti; Beatrice Alessandria; Silvia Mioletti; Giovanni Donati; Gianmauro Numico; Simone Cenci; Paolo Cascio

Based on promising results in preclinical models, clinical trials have been performed to evaluate the efficacy of the first-in-class proteasome inhibitor bortezomib towards malignant pleural mesothelioma (MPM), an aggressive cancer arising from the mesothelium of the serous cavities following exposure to asbestos. Unexpectedly, only minimal therapeutic benefits were observed, thus implicating that MPM harbors inherent resistance mechanisms. Identifying the molecular bases of this primary resistance is crucial to develop novel pharmacologic strategies aimed at increasing the vulnerability of MPM to bortezomib. Therefore, we assessed a panel of four human MPM lines with different sensitivity to bortezomib, for functional proteasome activity and levels of free and polymerized ubiquitin. We found that highly sensitive MPM lines display lower proteasome activity than more bortezomib-resistant clones, suggesting that reduced proteasomal capacity might contribute to the intrinsic susceptibility of mesothelioma cells to proteasome inhibitors-induced apoptosis. Moreover, MPM equipped with fewer active proteasomes accumulated polyubiquitinated proteins, at the expense of free ubiquitin, a condition known as proteasome stress, which lowers the cellular apoptotic threshold and sensitizes mesothelioma cells to bortezomib-induced toxicity as shown herein. Taken together, our data suggest that an unfavorable load-versus-capacity balance represents a critical determinant of primary apoptotic sensitivity to bortezomib in MPM.


Anatomia Histologia Embryologia | 2016

Spontaneous Age‐related Changes of Peripheral Nerves in Cattle: Morphological and Biochemical Studies

E. Biasibetti; D Bisanzio; Silvia Mioletti; S. Amedeo; A Iuliano; Paolo Bianco; Maria Teresa Capucchio

Peripheral nerve function is significantly affected by ageing. During ageing process, multiple changes occur on tissue cells and extracellular matrix. The aim of this work was to study the ageing‐associated changes of peripheral nerves in adult and old regularly slaughtered cattle compared with young calves, and correlate them to the features reported in humans and laboratory animals. Samples of axial dorsal metacarpal nerves from 44 cows were collected immediately after slaughtering. Each nerve was dissected and divided into two fragments: one used for morphological evaluation (n = 43) and the other one for biochemical analysis (n = 31). Axonal degeneration, demyelination, thickness of perineurium and endoneurium and increase of mast cells were the most important features detected. The mean amount of glycosaminoglycan quantitative content recorded in the samples increased with the age. Axonal degeneration, demyelination and thickness of endoneurium were positively and significantly correlated with biochemistry. The presence of changes affecting the different elements of the peripheral nerves, similar to that reported in humans and in laboratory species, the easy availability of the nerve tissue in this species, the considerable size of the samples and the life conditions more similar to humans than to laboratory animals, allows the authors to consider cattle as a potential good model for the comparative study of spontaneous ageing nerve lesions.


Biochemical Journal | 1996

Affinity purification and characterization of protein gene product 9.5 (PGP9.5) from retina.

Marco Piccinini; Adalberto Merighi; R. Bruno; Paolo Cascio; M. Curto; Silvia Mioletti; Clarissa Ceruti; Maria Teresa Rinaudo


Journal of Neurobiology | 2004

In vivo analysis reveals different apoptotic pathways in pre- and postmigratory cerebellar granule cells of rabbit

Laura Lossi; Graziana Gambino; Silvia Mioletti; Adalberto Merighi


Journal of Comparative Pathology | 2018

Intramural Coronary Arteriosclerosis in Beef Cattle Reared Under Different Housing Conditions

Ilaria Biasato; E. Biasibetti; S. Dellarole; B. Miniscalco; Silvia Mioletti; M. Tarantola; Davide Biagini; P. Capra; M. Leporati; M. Vincenti; F. Guarda; Maria Teresa Capucchio

Collaboration


Dive into the Silvia Mioletti's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge